ArticleInvestigative ophthalmology & visual science2012

Retinoblastoma treatment: utilization of the glycolytic inhibitor, 2-deoxy-2-fluoro-D-glucose (2-FG), to target the chemoresistant hypoxic regions in LH(BETA)T(AG) retinal tumors.

Yolanda Piña et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.